Beta Bionics Inc
This cross-functional role supports Corporate Development, Investor Relations, and Clinical Operations initiatives within a fast-paced medical technology environment. The position involves evaluating M&A opportunities, developing investor-facing narratives, and contributing to clinical trial strategies that align with the company's financial and strategic priorities. The ideal candidate will leverage financial, commercial, and clinical analysis to drive business growth and engage with capital markets.
Headquarters
Irvine, California, United States
Company Size
51-200 employees
Founded
2015
Beta Bionics is a medical device company developing the iLet Bionic Pancreas, an automated insulin-delivery system designed to learn and adapt to each user so people with insulin-requiring diabetes can stop doing the math and manual dosing. The iLet combines pump hardware, control algorithms, and continuous glucose monitoring to provide closed‑loop glucose management that minimizes day‑to‑day decision making. Beta Bionics positions the technology to simplify diabetes care and restore freedom and quality of life for people who rely on insulin.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Beta Bionics Inc.
Right around the average for this role
Sr. Manager, Corporate Development & Investor Relations
Trex Company
Senior Associate, Corporate Development & Investor Relations
DriveWealth
Investor Relations Manager
Axalta
Vice President, Investor Relations & Corporate Development
Saildrone
Director, Corporate Development & Investor Relations
Airwallex
Director, Corporate Development & Investor Relations
Airwallex